these are not equity shares which will be issued on prefference but the above said are prefferential shares of 5 rs each. these will carry intrest (dividend).The debt will come down significantly at the same time the equity will not be diluted.
160 crs pref shares of rs 5 each ,that is
160 cr * 5 = 800 crs
what wockhardt stated "Drug maker Wockhardt said on Wednesday it plans a preferential issue of up to 1.6 billion convertible or non-convertible redeemable preference shares at Rs 5 each"
this issue will carry an fixed amount of interest(Dividend) whether declared for ordinary share holder but will be payable to the Preferential share holder i.e. under CDR scheme banks/institution opted in terms of debt in the form of shares. these may be converted after a long period or may not as the wishes of share holder.
what you want to say Mr. Lion
Please remember this issue is to be delt with CDR not any adverse. its beginning of good news as Tara stated.
Lower revenues expectations due to recent restructuring of subsideries. PAT may be turn to be positive this qtr. This is due to lower intrest charges (50 cr) and taxes (20 cr) in Q4. Depreciation will be at 30 cr and FCCB premium may be 10 crs.
Currency fluctuations may not have nagetive impact on wock`s PAT.
There may be capitalisation of R&D expenditures
ACTUALS REPORTED
Revenues were at 9227 mn
EBITDA at 182 crs
Intrest at 51.5 crs
FCCB premium at 9 crs
Depreciation at 29.5 crs
TAX at 16.5 crs
| NIFTY 
